GlassScriptPhysician profile
Peter Nicholas Manos
NPI 1558335083
$1,544.94
in general payments reported to CMS, 2019-2025
24 companies · $45.01 in 2025
The $45.01 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $216 · 2021: $339 · 2022: $289 · 2023: $365 · 2024: $27.44 · 2025: $45.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $186.94 | 2019-2023 | Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.34 | 2019-2023 | Ofev |
| Grifols USA, LLC | $163.36 | 2019-2023 | Prolastin-C Liquid |
| Insmed, INC. | $116.18 | 2019-2023 | Arikayce |
| Glaxosmithkline, LLC. | $110.36 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $95.55 | 2020-2022 | |
| Inspire Medical Systems, INC. | $80.94 | 2023-2025 | Inspire |
| Mylan Specialty L.P. | $80.25 | 2019-2023 | Yupelri |
| Jazz Pharmaceuticals INC. | $70.42 | 2021-2023 | |
| Baxter Healthcare | $54.20 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Harmony Biosciences LLC | $53.75 | 2020-2023 | Wakix |
| Advanced Respiratory, INC | $38.89 | 2020-2021 | |
| Genentech USA, INC. | $36.12 | 2019 | |
| Amgen INC. | $35.76 | 2022-2023 | Tezspire |
| Astellas Pharma US INC | $35.69 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $35.63 | 2023 | |
| Mallinckrodt Enterprises LLC | $28.05 | 2019 | |
| Ani Pharmaceuticals, INC. | $27.44 | 2024 | Purified Cortrophin Gel |
| Inogen, INC. | $21.01 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $20.15 | 2023 | Quviviq |
| Philips North America LLC | $20.07 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.02 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.87 | 2021 | |
| Axsome Therapeutics, INC. | $12.95 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Manos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.